[Ultrastructural study of azidothymidine-induced melanoderma in an AIDS patient]

Related Experiment Video

Updated: Nov 8, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

T Hermanns-Lê1, F Gérardy-Goffin, M Giet-Lesuisse

  • 1Service de Dermatopathologie, CHU du Sart Tilman, Université de Liège.

Annales De Pathologie
|January 1, 1993
PubMed

Insights

Azidothymidine causes skin hyperpigmentation by increasing melanin production and impairing melanosome degradation in keratinocytes and dermal cells. This ultrastructural study reveals melanosomes in epidermal cells and Factor XIIIa-positive dendrocytes, suggesting a maturation defect.

Area of Science:

  • Dermatology
  • Cell Biology
  • Pharmacology

Background:

  • Azidothymidine (AZT) is an antiretroviral medication.
  • Melanoderma is a condition characterized by skin hyperpigmentation.
  • The ultrastructural mechanisms of AZT-induced melanoderma are not fully understood.

Observation:

  • Ultrastructural analysis of azidothymidine-induced melanoderma was performed.
  • Numerous single melanosomes and polymelanosomes were observed.
  • These melanosomes were present in keratinocytes throughout the epidermis and in dermal Factor XIIIa-positive dendrocytes.

Findings:

  • Azidothymidine induces hyperpigmentation.
  • Increased melanogenesis in melanocytes is suggested.
  • A defect in melanosome degradation during epidermal maturation is indicated.

Implications:

  • The findings provide insight into the cellular mechanisms of drug-induced hyperpigmentation.
  • Understanding melanosome processing defects may inform future therapeutic strategies.
  • This study highlights potential side effects of azidothymidine treatment on skin pigmentation.

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...